SCHEMBL31049362

SCHEMBL31049362

N#Cc1c(CCCCn2cc(Br)cn2)[nH]c2c(F)cc(F)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31049269 0.73 ALDH1A1 (0.35) —
SCHEMBL31049503 0.72 AR (0.32) —
SCHEMBL31049408 0.72 IP6K1 (0.32) —
SCHEMBL31049371 0.67 ALDH1A1 (0.34) —
SCHEMBL31049293 0.67 ALDH1A1 (0.34) —
SCHEMBL31049388 0.65 MEN1 (0.33) —
SCHEMBL31049273 0.63 REN (0.33) —
SCHEMBL16065410 0.60 ALDH1A1 (0.40) —
SCHEMBL17406960 0.60 ALDH1A1 (0.40) —
SCHEMBL1857877 0.60 ALDH1A1 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118359627-A MTA synergistic PRMT5 inhibitor compounds having a tetracyclic fused ring structure 烨辉医药科技(上海)有限公司 2024-07-19 — — CN disclosed
Send feedback